Cantourage Group has acquired SUMO Cannabis as a partner to supply to the European market for medicinal cannabis. Patients in Germany, who can already obtain medical cannabis as a medicine through pharmacies, will thus benefit from an even better supply of high-quality cannabis flowers in the future.
SUMO Cannabis maintains its cultivation operation in Trois-Rivières, in the heart of the province of Québec, Canada. With currently 25 employees, the company has been licensed under the Cannabis Act and Cannabis Regulations (Health Canada) since February 2022 and operates an aeroponic cultivation facility that allows for particularly resource-efficient cultivation. In addition to very low energy and water consumption, this cultivation practice gives growers full control over important parameters such as nutrient content and pH levels.
With the approval of the cultivar Apex OG, Cantourage is expanding its product range in the craft cannabis segment and thus strengthening the security of supply for patients in Germany.
“We are excited to offer our flowers to the European market for the first time, a significant milestone for our young company. The partnership will allow us to share our passion for premium cannabis with the discerning patients in Germany, offering them even more choices of high-quality medical cannabis strains,” said Éric Morel, CEO of SUMO Cannabis.
“We are delighted to have gained another cultivation partner in SUMO Cannabis, who shares our passion for cannabis products. More and more international growers are actively seeking to work with us, which shows that our model works and is seen as exemplary in the industry,” added Philip Schetter, CEO of Cantourage.
For more information:
Cantourage 
www.cantourage.com